Literature DB >> 29654688

Entamoeba histolytica L220 induces the in vitro activation of macrophages and neutrophils and is modulated by neurotransmitters.

Fabiola Del Rocío Villalobos-Gómez1,2, Mario García-Lorenzana3, Galileo Escobedo4, Patricia Talamás-Rohana5, Rogelio Salinas-Gutiérrez6, Verónica-Ivonne Hernández-Ramírez5, Esperanza Sánchez-Alemán1, María Del Rosario Campos-Esparza1, Martín Humberto Muñoz-Ortega7, Javier Ventura-Juárez1.   

Abstract

The neuroimmunoregulation of inflammation has been well characterized. Entamoeba histolytica provokes an inflammatory response in the host in which macrophages and neutrophils are the first line of defense. The aim of this study was to analyze the effect of the 220 kDa lectin of Entamoeba histolytica on stimulation of human macrophages and neutrophils, especially the secretion of cytokines and the relation of these to neurotransmitters. Human cells were interacted with L220, epinephrine, nicotine, esmolol and vecuronium bromide. The concentrations of IL-1β, IFN-γ, TNF-α and IL-10 were determined by ELISA at, 4 h of interaction. L220 has a cytokine stimulating function of macrophages and neutrophils for secretion of IL-1β, and IL-10 only by macrophages, which was modulated by the effect of vecuronium on cholinergic receptors in this immune cells.

Entities:  

Keywords:  L220 Entamoeba histolytica; cytokines; epinephrine; esmolol; macrophages; neutrophils; nicotine; vecuronium bromide

Mesh:

Substances:

Year:  2018        PMID: 29654688     DOI: 10.1515/ap-2018-0031

Source DB:  PubMed          Journal:  Acta Parasitol        ISSN: 1230-2821            Impact factor:   1.440


  1 in total

1.  Functional Characterization of an Interferon Gamma Receptor-Like Protein on Entamoeba histolytica.

Authors:  Julieta Pulido-Ortega; Patricia Talamás-Rohana; Martín Humberto Muñoz-Ortega; Liseth Rubí Aldaba-Muruato; Sandra Luz Martínez-Hernández; María Del Rosario Campos-Esparza; Daniel Cervantes-García; Aralia Leon-Coria; France Moreau; Kris Chadee; Javier Ventura-Juárez
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.